High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

Show other versions (1)

OBJECTIVE: Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-α (HNF1A) is often misdiagnosed as type 1 diabetes or type 2 diabetes. Recent work has shown that high-sensitivity C-reactive protein (hs-CRP) levels are lower in HNF1A-MODY than type 1 dia...

Full description

Bibliographic Details
Main Authors:	McDonald, T, Shields, B, Lawry, J, Owen, K, Gloyn, A, Ellard, S, Hattersley, A
Format:	Journal article
Language:	English
Published:	2011

Similar Items

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
by: McDonald, T, et al.
Published: (2011)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
by: McDonald, T, et al.
Published: (2012)

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
by: Owen, K, et al.
Published: (2013)

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
by: Mughal, SA, et al.
Published: (2014)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
by: Mughal, SA, et al.
Published: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
by: Nowak, N, et al.
Published: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
by: Nowak, N, et al.
Published: (2013)

The role of the HNF4alpha enhancer in type 2 diabetes.
by: Mitchell, S, et al.
Published: (2002)

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes
by: Mitchell, S, et al.
Published: (2002)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
by: Selwood, M, et al.
Published: (2008)

Integration of biomarkers and clinical characteristics provides the best method for identifying patients with MODY
by: Shields, B, et al.
Published: (2012)

Altered cortisol metabolism in individuals with HNF1A-MODY
by: Juszczak, A, et al.
Published: (2020)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
by: Owen, K, et al.
Published: (2010)

The common p.R114W HNF4A mutation causes a distinct clinical subtype of monogenic diabetes
by: Laver, T, et al.
Published: (2016)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
by: Juszczak, A, et al.
Published: (2018)

Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes
by: Misra, S, et al.
Published: (2020)

Asian MODY: are we missing an important diagnosis?
by: Porter, JR, et al.
Published: (2006)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
by: Harries, L, et al.
Published: (2009)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
by: Thomson, K, et al.
Published: (2003)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
by: Gloyn, A, et al.
Published: (2011)

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes
by: Thanabalasingham, G, et al.
Published: (2011)

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
by: Thanabalasingham, G, et al.
Published: (2011)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
by: Jafar-Mohammadi, B, et al.
Published: (2009)

When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes
by: Althari, S, et al.
Published: (2016)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY
by: Steele, A, et al.
Published: (2011)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
by: Steele, A, et al.
Published: (2011)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018)

A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population.
by: Weedon, M, et al.
Published: (2005)

Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene.
by: Gloyn, A, et al.
Published: (2002)

Role of low frequency variants in HNF1A exons 8-10 encoding hepatocyte nuclear factor-1 alpha isoform A to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2010)

Diagnosis and management of maturity onset diabetes of the young (MODY).
by: Thanabalasingham, G, et al.
Published: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY).
by: Thanabalasingham, G, et al.
Published: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY)
by: Thanabalasingham, G, et al.
Published: (2011)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
by: Mughal, SA, et al.
Published: (2013)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
by: Mughal, SA, et al.
Published: (2013)

A role for coding functional variants in HNF4A in type 2 diabetes susceptibility
by: Jafar-Mohammadi, B, et al.
Published: (2011)

A role for coding functional variants in HNF4A in type 2 diabetes susceptibility.
by: Jafar-Mohammadi, B, et al.
Published: (2011)

Early developmental perturbations in a human stem cell model of MODY5/HNF1B pancreatic hypoplasia
by: Teo, Adrian Kee Keong, et al.
Published: (2018)